Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), a premiere, fully licensed California-based cannabis company, today announces that the Company has achieved another technological milestone in its proprietary manufacturing process for its patented, disruptive Hourglass™ time-release THC+ cannabinoid delivery cream. Continued research and analysis of the Hourglass manufacturing process have allowed the Company to substantially reduce the size of the cream’s THC/CBD-infused particles to a mean particle size of 8.2 microns, as compared to previous samples, which averaged 33.1 and 29.9 microns. Grapefruit’s progress in consistently reducing the size of the infused particles meaningfully increases the bioavailability of the Hourglass’ active ingredients.*

Bradley Yourist, Grapefruit CEO, stated, “We constantly strive to improve the quality of our Hourglass time-release THC+ cannabinoid delivery cream so our clientele is always the beneficiary of the best possible full-spectrum entourage experience we can deliver. We performed several particle size analyses on the structure of the Hourglass cream as part of our manufacturing protocols in an effort to fine tune the process and produce a cream capable of delivering the best possible experience to Hourglass users. Our efforts have paid dividends. We are currently in the process of adapting our proprietary manufacturing protocols to our new hemp-derived CBD cream. No CBD competitor’s topical products will be able match the consistency and technology of our hemp-derived CBD creams to deliver Hourglass’ stellar results.”

The first accompanying chart shows the latest sample (blue curve) and the comparison to the previous samples (brown and red). The new sample contains smaller particles with a mean particle size of 8.2 microns, as compared to 33.1 and 29.9 microns for the samples tested in January 2021. 

“To put that into perspective,” Yourist said, “the size of a human hair is approximately 75 microns wide. The latest sample is in the 90^th percentile or 14.2 microns, compared to 78 microns and 70 microns for the prior samples. The average particle size is smaller and the particle size distribution is narrower for the most recent sample, thereby increasing the bioavailability of the cream’s ingredients.”*

The second set of charts demonstrates the improvement in Grapefruit’s proprietary manufacturing process from January 2021 to March 2021.

“Grapefruit’s Hourglass™ Topical Delivery Cream has fundamentally changed the way individuals use THC/CBD and other cannabinoids to obtain their holistic benefits and will continue to do so for the foreseeable future.* Grapefruit’s hemp-based topical CBD creams will be Hourglass-based and will include all of our fundamental advances,” Yourist added.

*This product is not regulated by the FDA and is not intended to cure, mitigate, treat or prevent disease.

To learn more about Grapefruit, please visit InvestorBrandNetwork:
https://www.investorbrandnetwork.com/clients/grapefruit-usa-inc/

To learn more about Grapefruit’s new sustained-release Hourglass™ THC+ cannabinoid topical delivery cream, please watch this promotional video https://www.youtube.com/watch?v=6cU9MJMgH1w&feature=youtu.be and visit our website at:
https://grapefruitblvd.com/hourglass/

To learn more about Grapefruit, please visit our website at:
https://grapefruitblvd.com/investor-relations/

Follow us on Facebook, Instagram, LinkedIn and Twitter
Facebook | Instagram | LinkedIn | Twitter

About Grapefruit

Grapefruit’s corporate headquarters is in Westwood, Los Angeles, California. Grapefruit holds California permits and licenses to both manufacture and distribute cannabis products in the Golden State. Grapefruit’s extraction laboratory and manufacturing and distribution facilities are located in the industry-recognized Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, located on the extension of North Canyon Road, approximately 14 miles north of downtown Palm Springs. To obtain further information on Grapefruit and its operations, please visit the Company’s website at https://grapefruitblvd.com/.

Safe Harbor Statement

Grapefruit cautions that any statement included in this press release that is not a description of historical facts is a forward-looking statement. Many of these forward-looking statements contain the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties inherent in Grapefruit’s business, including, without limitation: the Company may not ever obtain additional funds necessary to support its business development and growth plans; and the Company may not ever achieve the market success to reach or sustain a profitable business. In addition, there are risks and uncertainties related to economic recession or terrorist actions, competition from much larger cannabis companies, unexpected costs and delays, potential product liability claims and many other factors. More detailed information about Grapefruit and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission, including the Company’s Annual Report on Form 10-K, its Quarterly Report on Form 10-Q for the period ended Sept. 30, 2020, and its Registration Statement on Form S-1/A. Such documents may be read free of charge on the SEC’s website at www.sec.gov. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, and Grapefruit undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.

Investor Relations Contact:
Bradley Yourist
This email address is being protected from spambots. You need JavaScript enabled to view it.
18776 Blue Dream Crossing, Unit LL1 53-07
Desert Hot Springs, California 92240
(760) 205-1382
https://grapefruitblvd.com/

Please be aware that our social media accounts can be used from time to time for additional material events. They can be found here:

Grapefruit USA:
Facebook: https://www.facebook.com/Grapefruit-Boulevard-2304698596251925/
Instagram: https://www.instagram.com/grapefruit_usa/
Twitter: https://twitter.com/grapefruitusa
LinkedIn: https://www.linkedin.com/company/grapefruit-boulevard/
Weedmaps: https://weedmaps.com/brands/grapefruit

Corporate Communications:
InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
This email address is being protected from spambots. You need JavaScript enabled to view it.